Evidence map›Paper›PMID 27349479›Full record

ArticleScientific reports2016

RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src.

Yi Pan, GuangMing Li, HengGao Zhong, MeiJuan Chen, TingTing Chen, LiLi Gao, HuiWen Wu, Jun Guo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Frontiers in pharmacology · 2022
    Article
  5. RIG-I Deficiency Promotes Obesity-Induced Insulin Resistance.Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  6. Underlying Mechanism of Insulin Resistance: A Bioinformatics Analysis Based on Validated Related-Genes from Public Disease Databases.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  7. Review
  8. Mechanisms of the Regulation and Dysregulation of Glucagon Secretion.Oxidative medicine and cellular longevity · 2020
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yi PanDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, PR China.
GuangMing LiDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, PR China.
HengGao ZhongDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, PR China.
MeiJuan ChenThe Pre-clinical Medicine College, Nanjing University of Chinese Medicine, Nanjing, PR China.
TingTing ChenDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, PR China.
LiLi GaoDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, PR China.
HuiWen WuLaboratory Center for Basic Medical Sciences, Nanjing Medical University, Nanjing, PR China.
Jun GuoDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, PR China.
Nanjing Medical University · CNHuaian First People’s Hospital · CNNanjing University of Chinese Medicine · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutrition is a necessary condition for cell proliferation, including pancreatic β cells; however, over-nutrition, and the resulting obesity and glucolipotoxicity, is a risk factor for the development of Type 2 diabetes mellitus (DM), and causes inhibition of pancreatic β-cells proliferation and their loss of compensation for insulin resistance. Here, we showed that Retinoic acid (RA)-inducible gene I (RIG-I) responds to nutrient signals and induces loss of β cell mass through G1 cell cycle arrest. Risk factors for type 2 diabetes (e.g., glucolipotoxicity, TNF-α and LPS) activate Src in pancreatic β cells. Elevated RIG-I modulated the interaction of activated Src and STAT3 by competitive binding to STAT3. Elevated RIG-I downregulated the transcription of SKP2, and increased the stability and abundance of P27 protein in a STAT3-dependent manner, which was associated with inhibition of β cell growth elicited by Src. These results supported a role for RIG-I in β cell mass loss under conditions of metabolic surplus and suggested that RIG-I-induced blocking of Src/STAT3 signalling might be involved in G1 phase cycle arrest through the Skp2/P27 pathway in pancreatic β cells.

Indexed as

Cell ProliferationAnimalsBinding, CompetitiveCell Line, TumorCyclin-Dependent Kinase Inhibitor p27DEAD Box Protein 58Diabetes Mellitus, Type 2Enzyme ActivationG1 Phase Cell Cycle CheckpointsHumansInsulin-Secreting CellsMaleMice, Inbred ICRSignal Transductionsrc-Family KinasesSTAT3 Transcription FactorCyclin-Dependent Kinase Inhibitor p27Ddx58 protein, mouseDEAD Box Protein 58src-Family KinasesSTAT3 Transcription Factor

Identifiers

PMID27349479
PMCPMC4923948
OpenAlexW2471640460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.